Cinglan 60 mg-Filmtabletten
Rückruf aufgrund verminderter Wirkstofffreisetzung
Publisher
Austria
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Rückruf aufgrund verminderter Wirkstofffreisetzung
Source route
Continue on basg.gv.at
Leave the platform to read the original full article on the publisher site.
Source: BASG Austria
Scope: Regulatory
Related coverage
More related coverage
Transparency data: Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2025-26
MHRA transactions over £500 made using the government procurement card (GPC).
Guidance: COVID-19 test validation approved products
Find out which COVID-19 test products have been approved.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare prod...
„Medikamente Info Austria“ liefert kompakte Medikamenten-Information im neuen Design
Mit 10. Februar 2026 beginnt der Echtbetrieb für das neue Medikamenten-Informationssystem des Bundes...